The latest thoracic oncology news
While pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer…
Cancer therapies that target specific genetic abnormalities in tumours have revolutionised treatment possibilities over the…
A global study, led by UCL and UCLH in the USA, has shown that the…
Tracheal, bronchus, and lung (TBL) cancer contributes significantly to the disease burden globally, increasing expenditure…
Small-cell lung cancer is a particularly aggressive tumour with a consistently high mortality rate. In recent…
Loss of two key “protector” proteins initiates epigenetic changes that transform healthy lung cells into…
Assistance from an artificial intelligence (AI) algorithm with high diagnostic accuracy improved radiologist performance in…
Researchers from The University of Texas MD Anderson Cancer Center, USA, found the KRAS G12C…
Researchers of the University of Barcelona and the Institute of Bioengineering of Catalonia (IBEC) in…
New research in the June 2023 issue of JNCCN (Journal of the National Comprehensive Cancer Network) found that…